InspireMD's MGuard Coronary:
This article was originally published in Clinica
Israeli firm InspireMD has received permission to CE mark its MGuard Coronary stent for the treatment of patients with coronary artery diseases. MGuard Coronary combines a coronary stent with an embolic protection device - an ultra-thin polymer mesh sleeve wrapped around the stent, designed to provide embolic shower protection during and after stenting. The sleeve expands when the stent is deployed without affecting the structure of the stent, and diffuses stent pressure on the vessel wall, and thereby may reduce injury and the likelihood of restenosis. The technology may also provide a drug delivery mechanism for next-generation drug-eluting stents. The Tel Aviv-based company claims it has "already received pre-launch orders valued at over $1.5m."